Get started
Live feed
·
INSIDERFilingvia Quantisnow
Kalaris Therapeutics Inc. logo

SEC Form 4 filed by Director Adamis Anthony P

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight
Quantisnow market dataNASDAQ
Kalaris Therapeutics Inc. logo
KLRS
Kalaris Therapeutics Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Listed since
2020
Get push alerts for KLRS

Follow KLRS and get a push notification the moment its next story breaks.

Full KLRS profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KLRS (Kalaris Therapeutics Inc.) and more on Quantisnow.